Skip to main content
. 2022 May 26;3:832880. doi: 10.3389/fgwh.2022.832880

Table 9.

Pooled prevalence of Plasmodium vivax infection in pregnant females.

References Sample size Proportion (%) 95% CI Weight (%)
Fixed Random
Ahmed et al. (11) 506 2.174 1.090–3.856 2.47 8.32
Singh et al. (12) 274 6.569 3.940–10.184 1.34 7.97
Bardaji et al. (14) 1,982 1.261 0.818–1.856 9.68 8.65
Hamer et al. (15) 3,104 0.580 0.344–0.915 15.16 8.70
Kuepfer et al. (16) 6,868 0.160 0.0800–0.286 33.53 8.74
Sohail et al. (18) 2,141 4.250 3.436–5.193 10.46 8.66
Singh et al. (19) 3,721 0.296 0.148–0.528 18.17 8.71
Corrêa et al. (20) 575 0.174 0.00440–0.965 2.81 8.37
Singh et al. (21) 203 29.557 23.374–36.347 1.00 7.72
Guin et al. (23) 500 1.000 0.325–2.318 2.45 8.31
Chawla and Manu (26) 416 1.923 0.834–3.754 2.04 8.23
Datta et al. (28) 183 26.776 20.512–33.809 0.90 7.62
Total (fixed effects) 20,473 0.864 0.742–1.001 100.00 100.00
Total (random effects) 20,473 3.463 1.740–5.748 100.00 100.00
Test for heterogeneity
Q 603.3980
DF 11
Significance level P < 0.0001
I2 (inconsistency) 98.18%
95% CI for I2 97.64–98.59
Publication bias
Egger's test
Intercept 10.0418
95% CI 3.4797–16.6040
Significance level P = 0.0067
Begg's test
Kendall's Tau 0.6364
Significance level P = 0.0040